Sun Pharmaceutical Industries Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is REGADENOSON, with a corresponding US DMF Number 31539.
Remarkably, this DMF maintains an Active status since its submission on November 24, 2017, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 08, 2017, and payment made on March 27, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II